Scioto Biosciences Company

Scioto Biosciences is a developer of Activated Bacterial Therapeutics (ABT) platform intended to deliver live bacteria to the gut. The company is developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics, enabling medical practitioners to advance healing through microbiome therapeutics.
Industry: Geroscience
Headquarters: Indianapolis, Indiana, United States
Zip: 51-100
Founded Date: 2017-01-01
Employees Number: 51-100
Acquisitions Number: 7
Investors Number: 30955000
Total Funding: $1M to $10M
Estimated Revenue: $1M to $10M
Last Funding Date: Series B
Last Funding Type: Series B

Visit Website
Register and Claim Ownership